A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?
OpenSymmetry
JULY 20, 2016
Sales in the pharmaceutical industry has been a rigid and consistent business. For example, Corporate Integrity Agreements (CIAs) were implemented by the DoJ as a way to curtail off-label drug promotion which forced companies to ensure their sales incentives encouraged proper compliance. Share your thoughts in the comments below!
Let's personalize your content